In 2025, the hernia mesh devices market was valued at USD 5.10 billion. Based on Future Market Insights' analysis, demand is estimated to grow to USD 5.27 billion in 2026 and USD 7.37 billion by 2036. FMI projects a CAGR of 3.40% during the forecast period.
| Metric | Details |
|---|---|
| Industry Size (2026) | USD 5.27 Billion |
| Industry Value (2036) | USD 7.37 Billion |
| CAGR (2026 to 2036) | 3.40% |
Source: Future Market Insights, 2026
The market is set to add approximately USD 2.09 billion in absolute terms between 2026 and 2036. Growing hernia repair surgical volumes driven by aging populations and rising obesity rates sustain mesh device demand, while litigation-driven product liability concerns (transvaginal mesh recall precedent) are compelling manufacturers to invest in biocompatible material development and post-market surveillance programmes. Lightweight large-pore polypropylene mesh designs are displacing heavyweight small-pore predecessors based on clinical evidence of reduced chronic pain and foreign body sensation. As per FMI, country-level growth rates through 2036 are projected as follows: China at 4.60%, India at 4.30%, Germany at 3.90%, France at 3.60%, UK at 3.20%, USA at 2.90%, Brazil at 2.60%. China records the fastest expansion driven by concentrated institutional investment and infrastructure development.
The hernia mesh devices market encompasses implantable surgical prostheses engineered for abdominal wall reinforcement during hernia repair procedures. Synthetic mesh products utilize polypropylene, polyester, and ePTFE materials in lightweight large-pore and heavyweight small-pore configurations, while biological mesh products employ decellularized extracellular matrix from human or animal tissue sources. FMI is of the opinion that the market is in a material specification evolution phase where lightweight synthetic designs and biological alternatives are displacing first-generation heavyweight mesh products, driven by clinical outcome data and product liability risk management considerations.
Market scope covers synthetic polypropylene, polyester, and ePTFE mesh implants, biological mesh derived from acellular dermal matrix and porcine submucosa, and composite mesh devices combining synthetic and absorbable components for all hernia repair indications.
Suture-only hernia repair without mesh reinforcement, hernia trusses and external support garments, and general surgical suture materials not classified as mesh implants are excluded.
According to a research published in the United Kingdom, the prevalence of hernias rises with age. The prevalence of hernia was found to be 5%, 10%, 18%, 24%, 31%, and 45% among the age groups of 25 - 34 years, 35 - 44 years, 45 - 54 years, 55 - 64 years, 65 - 74 years and 75 years and above, respectively.
The advancements such as self-fixating meshes and articulating fixation are achieved to overcome the issues, which makes it a key factor for the growth in the adoption of hernia mesh devices. The cost of raw material for hernia mesh though subjected to market volatility has never crossed USD 1,500 in any year providing a necessary profit margin to the manufacturer of hernia mesh devices.
Over 4.9 Million hernia operations take place worldwide annually. Non-degradable hernia surgical mesh implants are characterized by poor healing response, and in vivo erosion which leads to over 10% failure rate and an estimated 42% of recurrent hernias. In 4.921, the average global price of polypropylene was USD 1,285 per ton as compared to 4.94.9, while prices have increased roughly by 36% between these years.
This increase in the price of raw materials for making synthetic mesh adversely affected the market revenue of polypropylene hernia mesh devices.
The 3-D printed biological mesh minimized post-surgical complications of hernia repair and its raw material such as human or porcine dermis is widely available and hence not subjected to market volatility effectively making their price constant. The manufacturing of biological mesh is highly reproducible and scalable and it can be modified depending on the patient’s background.
The cost-utility of a biological mesh device with a 3-D printing technique for the treatment of hernia is not cost-effective for the hospital or surgeons who pay the retail price of the product but it is cost-effective from a third-party payer perspective like medical reimbursement by the government interventions. The cost of 3D printed biological mesh will be USD 1,813 which is cost-effective regardless of size, furthermore making it significantly lower than the current retail cost of synthetic mesh.
North America is anticipated to grow at 3.4% CAGR during the forecast period 2026 to 2036. In North America, the reimbursement policy for hernia mesh is favorable to the patients, which encourages them to choose laparoscopic surgery.
Patients have simple access to detailed payment codes and ratios that governments and industry players make public. In addition, technical improvements and the introduction and acceptance of new products, such as TELA Bio, are boosting the market forward.
.webp "Top Country Growth Comparison Hernia Mesh Devices Market Cagr (2026 2036)")
The United States will account for over 34% of the global Hernia Mesh Devices Market by the year 2036, representing it as a fertile ground for hernia mesh device manufacturers, especially synthetic mesh devices. Hernia Mesh Devices Market will grow a USD 2.9% CAGR between 2026 and 2036 for the United States.
The global annual death rate of hernia per 4.300 thousand individuals is 0.5, according to Health Grove. According to statistics by FDA, more than 4.3 Million hernia procedures happen annually in the United States out of which, about 800 thousand procedures are of the inguinal type, making it one of the largest market for Hernia Mesh Devices.
Hernia mesh devices revenue in China is expected to witness an absolute dollar opportunity of USD 5.4.3 Million during 2026 - 2036. With a projected CAGR of 2.6%, China will become a USD 7.4.3 Million Hernia Mesh Devices Market by the end of 2036.
It was observed that the number of tension-free hernia repair operations in China reached 4.3 Million in 204.35 with an increase of 20%-30% in such operations each year. In particular, an inguinal hernia is more prominent with a male-to-female ratio of 8.2 to 4.3.
According to China’s Hernia Registry, adult inguinal hernia also accounts for the largest proportion of 83.3%. A report by medical service information, 204.38, the cost of a single case of inguinal hernia was USD 922.6, indicating that cost control in county-wide hospitals was good, further creating a robust demand for hernia mesh devices in China.
Inguinal hernia constitutes the most revenue from sales of hernia mesh devices. Inguinal hernias account for over 80% of all hernias. It is also 10X more common in men than in women, thus necessitating the need for correction.
Hernia repair for primary and incisional hernias is the most common abdominal surgery performed all around the globe, according to the International Journal of Abdominal Wall and Hernia Surgery. Men have a 27-43% and women have a 3-6% lifetime risk of developing an inguinal hernia. It is expected to trigger the growth of hernia repair market.
Patient feasibility due to tension-free procedures and post-operative complications involved in classic surgical techniques are also contributing to the demand for Inguinal Hernia Mesh. In addition, the recurrence rate for inguinal hernia is 1-3%, which further imparts strain on the hernia mesh devices revenue.
A procedure of synthetic mesh for hernia repair surgery which ranges from USD 4,200 to USD 12,500 has hurt the capitalization of the Hernia Mesh Devices Market. Synthetic Mesh is used in around 90% of hernia surgeries according to FDA. In the Asia Pacific where 99% of Hernia surgery is performed with Synthetic Mesh, there is a significant growth opportunity for biological mesh for based hernia repair devices.
On the other hand, the biological mesh has yet to reach the majority of the consumers as it is still in the research process hence it captures only around 1% of the global Hernia Mesh Devices market.
Most of the leading players in hernia mesh devices market have been focusing on obtaining approvals from regulatory authorities.
The key companies operating in the Hernia Mesh Devices market include Medtronic plc, Ethicon, and W. L. Gore and Associates, Inc., Atrium Medical Technologies, B. Braun Melsungen AG, PRIMEQUAL SA, Becton, Dickinson, and Company, Deep Blue Medical Inc., Dipromed Srl, BioCer Entwicklungs-GmbH, Betatech Medical, Sinolinks Medical Innovation, Inc, Aspide Medical S.A.S., Meril Life Sciences Pvt. Ltd., Herniamesh Srl., Changzhou Medical Equipment General Factory Co., Ltd, Gem Srl, SAMYANG HOLDING CORPORATION, Katsan Katgut Sanayi Ve Ticaret Anonim Sirketi, Novus Scientific AB.
Similarly, recent developments related to companies manufacturing hernia Mesh Devices have been tracked by the team at Future Market Insights, which is available in the full report.
| Metric | Value |
|---|---|
| Quantitative Units | USD 5.27 Bn to USD 7.37 Bn, at a CAGR of 3.40% |
| Market Definition | Hernia mesh devices are implantable surgical prostheses constructed from synthetic (polypropylene, polyester, ePTFE) or biological (acellular dermal matrix, porcine submucosa) materials used to reinforce weakened abdominal wall tissue during inguinal, incisional, femoral, and ventral hernia repair procedures. |
| Mesh Type Segmentation | Synthetic Mesh, Biological Mesh |
| Hernia Type Segmentation | Inguinal Hernia, Incisional Hernia, Femoral Hernia, Others |
| Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa |
| Countries Covered | China, India, Germany, France, UK, USA, Brazil, and 40 plus countries |
| Key Companies Profiled | Medtronic plc, Ethicon (Johnson & Johnson), W. L. Gore and Associates, Inc., Atrium Medical Technologies, B. Braun Melsungen AG, Cook Medical, Integra Lifesciences, Dipro Medical Devices S.R.L., Via Surgical, PRIMEQUAL SA, Becton Dickinson, Meril Life Sciences Pvt. Ltd. |
| Forecast Period | 2026 to 2036 |
| Approach | Hybrid bottom-up and top-down modeling validated against primary research inputs and publicly available industry data. |
This bibliography is provided for reader reference. The full FMI report contains the complete reference list with primary research documentation.
How large is the demand for Hernia Mesh Devices in the global market in 2026?
Demand for Hernia Mesh Devices in the global market is estimated to be valued at USD 5.27 billion in 2026.
What will be the market size of Hernia Mesh Devices by 2036?
Market size for Hernia Mesh Devices is projected to reach USD 7.37 billion by 2036.
What is the expected demand growth between 2026 and 2036?
Demand is expected to grow at a CAGR of 3.40% between 2026 and 2036.
Which Mesh Type is poised to lead by 2026?
Synthetic Mesh accounts for 61.0% in 2026.
How significant is Inguinal Hernia in driving adoption?
Inguinal Hernia represents 48.7% of segment share in 2026.
What country records the fastest growth?
China is projected to grow at a CAGR of 4.60% during 2026 to 2036.
What is the projected growth for India?
India is projected to expand at a CAGR of 4.30% during 2026 to 2036.
What is included in the scope of this report?
Market scope covers synthetic polypropylene, polyester, and ePTFE mesh implants, biological mesh derived from acellular dermal matrix and porcine submucosa, and composite mesh devices combining synthetic and absorbable components for all hernia repair indications.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Hernia Mesh Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
